Genetic determinants of drug responsiveness and drug interactions
Y Caraco - Therapeutic drug monitoring, 1998 - journals.lww.com
Six cytochrome P450 enzymes mediate the oxidative metabolism of most drugs in common
use: CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4. These enzymes have …
use: CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4. These enzymes have …
Genetic determinants of drug responsiveness and drug interactions.
Y Caraco - Therapeutic Drug Monitoring, 1998 - europepmc.org
Six cytochrome P450 enzymes mediate the oxidative metabolism of most drugs in common
use: CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4. These enzymes have …
use: CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4. These enzymes have …
Genetic Determinants of Drug Responsiveness and Drug Interactions
Y Caraco - Therapeutic Drug Monitoring, 1998 - journals.lww.com
Six cytochrome P450 enzymes mediate the oxidative metabolism of most drugs in common
use: CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4. These enzymes have …
use: CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4. These enzymes have …
[引用][C] Genetic determinants of drug responsiveness and drug interactions
Y CARACO - Therapeutic drug monitoring, 1998 - pascal-francis.inist.fr
Genetic determinants of drug responsiveness and drug interactions CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Genetic determinants of drug responsiveness and drug interactions
Y Caraco - Therapeutic drug monitoring, 1998 - pubmed.ncbi.nlm.nih.gov
Six cytochrome P450 enzymes mediate the oxidative metabolism of most drugs in common
use: CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4. These enzymes have …
use: CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4. These enzymes have …